Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Ng

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Microbiology|August 6, 2005
Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodiesSansan Lin, Phillip Arcangel, Angelica Medina-Selby, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaquesNicola Brunetti-Pierri, Aimee Liou, Priti Patel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 27, 2025
Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase 1 (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondriaIolanda Boffa, Rosa Ferriero, Mariarosaria Cancelliere, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cellsJan-Michael Prill, Sigrid Espenlaub, Ulrike Samen, et al.
Molecular Genetics and Metabolism|May 27, 2018
Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapySuhail Khoja, Matt Nitzahn, Kip Hermann, et al.
Human Gene Therapy|April 14, 2006
Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primatesNicola Brunetti-Pierri, Thomas Ng, David A Iannitti, et al.
Viruses|January 29, 2010
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus VaccinesEric A Weaver, Pramod N Nehete, Bharti P Nehete, et al.
Human Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.
Journal of Virology|February 22, 2008
High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunityGwendalyn D King, A K M Ghulam Muhammad, Weidong Xiong, et al.
Vaccine|November 16, 2004
Cationic microparticles are a potent delivery system for a HCV DNA vaccineDerek T O'Hagan, Manmohan Singh, Christine Dong, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Microbiology|August 6, 2005
Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodiesSansan Lin, Phillip Arcangel, Angelica Medina-Selby, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaquesNicola Brunetti-Pierri, Aimee Liou, Priti Patel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 27, 2025
Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase 1 (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondriaIolanda Boffa, Rosa Ferriero, Mariarosaria Cancelliere, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cellsJan-Michael Prill, Sigrid Espenlaub, Ulrike Samen, et al.
Molecular Genetics and Metabolism|May 27, 2018
Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapySuhail Khoja, Matt Nitzahn, Kip Hermann, et al.
Human Gene Therapy|April 14, 2006
Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primatesNicola Brunetti-Pierri, Thomas Ng, David A Iannitti, et al.
Viruses|January 29, 2010
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus VaccinesEric A Weaver, Pramod N Nehete, Bharti P Nehete, et al.
Human Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.
Journal of Virology|February 22, 2008
High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunityGwendalyn D King, A K M Ghulam Muhammad, Weidong Xiong, et al.
Vaccine|November 16, 2004
Cationic microparticles are a potent delivery system for a HCV DNA vaccineDerek T O'Hagan, Manmohan Singh, Christine Dong, et al.
Pageof 11